# A Study of MCARH109 and MCARH125 in People With Multiple Myeloma

> **NCT05431608** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 15 (actual)

## Conditions studied

- Multiple Myeloma
- Refractory Multiple Myeloma
- Relapse Multiple Myeloma

## Interventions

- **BIOLOGICAL:** MCARH125
- **BIOLOGICAL:** MCARH109

## Key facts

- **NCT ID:** NCT05431608
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-20
- **Primary completion:** 2026-06-20
- **Final completion:** 2026-06-20
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05431608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05431608, "A Study of MCARH109 and MCARH125 in People With Multiple Myeloma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05431608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*